Prioritising the application of genomic medicine-Reference-Cited by-同舟云学术

Prioritising the application of genomic medicine

Published:2017-11-21 Issue:1 Volume:2 Page:
ISSN:2056-7944
Container-title:npj Genomic Medicine
language:en
Short-container-title:npj Genomic Med

Author:

Doble Brett^ORCID,Schofield Deborah J.,Roscioli Tony,Mattick John S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41525-017-0037-0.pdf

Reference46 articles.

1. Technology Evaluation Center. Special Report: Exome Sequencing for Clinical Diagnosis of Patients with Suspected Genetic Disorders Vol. 28 (BlueCross BlueShield Association, Chicago, 2015).

2. Lionel, A. C. et al. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet. Med. https://doi.org/10.1038/gim.2017.119 (2017).

3. Stark, Z. et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet. Med. https://doi.org/10.1038/gim.2016.221 (2017).

4. Stavropoulos, D. J. et al. Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine. npj Genomic Medicine 1, 15012 (2016).

5. Caudle, K. E. et al. Incorporation of pharmacogenomics into routine clinical practice: the clinical pharmacogenetics implementation consortium (CPIC) guideline development process. Curr. Drug Metab. 15, 209–217 (2014).

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physician and informal care use explained by the Pediatric Quality of Life Inventory (PedsQL) in children with suspected genetic disorders;Quality of Life Research;2024-05-14

2. Identifying the genetic causes of developmental disorders and intellectual disability in Africa: a systematic literature review;Frontiers in Genetics;2023-05-10

3. A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact;Pharmaceutics;2023-04-19

4. Genomics in reproductive medicine: Current and future applications;Human Reproductive and Prenatal Genetics;2023

5. Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry;Pharmacogenetics and Genomics;2022-02-21